49 /100
MEDIUM RISK
Score updated May 30, 2026

WBUY — WEBUY GLOBAL LTD. Dilution Risk Tracker

Track WBUY dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track WBUY — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
48%
🔁 Convertible Conversion 60%
• Major convertible overhang: 36% potential dilution
• Convertible risk score very high (85/100)
📉 Score Deterioration 40%
• Score rose 29 points recently (worsening)
🔄 Reverse Split 30%
• 50-day avg $1.14 approaching $1 threshold
🔔 Track WBUY — Get forecast alerts →

💹 Market Data

Market Cap$5.54M
Shares Outstanding5.20M
Float4.45M
Cash$4.32M
Debt$2.39M
Short InterestN/A

🏛 Institutional Holdings

4 institutional holders · 30.3K shares
#1 Virtu Financial LLC 15.1K shares
#2 UBS Group AG 4.8K shares
#3 Vanguard Personalized Indexing Management, LLC 10.3K shares
+ 1 more holders Sign up free to view →

📉 Short Interest

Short Interest108.8K
Days to Cover3.1
% of Float2.5%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track WBUY Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking WBUY — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for WBUY
📊 WBUY FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 WBUY Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.